Kidney Function in Rats Treated With a High-Fructose Diet and Streptozotocin by Cristina Harumi Tozaki Azevedo et al.
International Journal of Food Science, Nutrition and Dietetics, 2014 © 109
Fernanda Teixeira Borges, et al (2014) Kidney Function in Rats Treated With a High-Fructose Diet and Streptozotocin. Int J Food Sci Nutr Diet. 3(4), 109-114.
International Journal of Food Science, Nutrition and Dietetics (IJFS) 
ISSN 2326-3350
Kidney Function in Rats Treated With a High-Fructose Diet and Streptozotocin
            
Review Article
Cristina Harumi Tozaki Azevedo1, Ellen de Oliveira Narciso Pitlovanciv1, Edson Andrade Pessoa1, Marcia Bastos Convento1, Nestor Schor1, Fernanda 
Teixeira Borges1,2.
1 Nephrology Division, Department of  Medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brasil.
2 Postgraduate Program, Health Sciences, CBS, Universidade Cruzeiro do Sul.
*Corresponding Author: 
Fernanda Teixeira Borges, 
Nephrology Division, Department of  Medicine, Universidade Federal de 
São Paulo (UNIFESP), São Paulo, Brasil.
Tel: 55(11) 5576-4242; Fax: 55(11) 5573-9652
E-mail: borgesft@nefro.epm.br
Received: February 24, 2014 
Accepted: April 05, 2014
Published: April 07, 2014
Citation: Fernanda Teixeira Borges, et al (2014) Kidney Function in Rats 
Treated With a High-Fructose Diet and Streptozotocin. Int J Food Sci 
Nutr Diet. 3(4), 109-114. doi: http://dx.doi.org/10.19070/2326-3350-
1400021
Copyright: Fernanda Teixeira Borges© 2014 This is an open-access 
article distributed under the terms of  the Creative Commons Attribution 
License, which permits unrestricted use, distribution and reproduction in 
any medium, provided the original author and source are credited. 
Introduction 
High fructose intake has been associated with metabolic syndrome 
in the United States [1]. Fructose is mainly present in breakfast 
cereals, high-fructose corn syrup, and soft drinks, which are con-
sumed in large amounts by the American population. Metabolic 
syndrome is characterized by specific signs as abdominal obesity, 
elevated triglycerides, reduced HDL-C, elevated blood pressure, 
and hyperglycemia [2, 3]. These signs are risk factors for cardio-
vascular disease and chronic kidney disease; they are designated as 
cardiorenal metabolic syndrome.
The link between obesity, insulin resistance, elevated plasma uric 
acid levels, non-alcoholic fatty liver, and cardiovascular or chronic 
kidney disease may be oxidative damage [4, 5].Obesity and ele-
vated plasma uric acid levels are associated with systemic oxida-
tive stress, inflammation, endothelial dysfunction, and pancreatic 
β-cell injury [5].
Fructose depletes ATP, increases nucleotide turnover and increas-
es plasma uric acid levels, impairing the renin-angiotensin-system 
and inducing oxidative stress [6]. Fructose-induced uric acid syn-
thesis in hepatocytes has lipogenic effects such as liver fatty acid 
accumulation and an increase in plasma triglycerides [7]. A high-
fructose diet also induces inflammation in hepatocytes and im-
pairment of  insulin signaling in the liver [8].
Adherence to a high fructose intake diet (HFID) for long periods 
is being used to mimic metabolic syndrome in rats. Studies have 
successfully induced metabolic syndrome in rats or mice using a 
60% fructose diet [9], usually during a long period of  treatment 
such as 8 months [10]. Nevertheless, other strategies potentiate 
or accelerate the development metabolic syndrome signs, such as 
cardiovascular or kidney diseases associated with this syndrome.
A study suggested that a high-fructose and high-fat diet could 
mimic some of  the signs of  metabolic syndrome [10]. In addition, 
another study suggested that fiber-free white flour together with 
fructose is more effective at triggering metabolic syndrome than 
only fructose [11].
The goal of  the present study was to analyze the association 
between high fructose intake in rats treated with low doses of  
streptozotocin, focusing on kidney function and histological al-
terations. In our model, the high-fructose diet induced some of  
the metabolic syndrome signs such as obesity, elevated triglycer-
ides, and increased plasma uric acid levels. In the rat kidney, an 
increased glomerular filtration area, urine volume, and urinary 
protein excretion, possibly mediated by an increase in kidney oxi-
dative stress, were observed. In animals treated with low doses 
of  streptozotocin and fructose, the same effects were observed 
except oxidative stress. Our work suggests that fructose together 
with low doses of  streptozotocin can potentiate, at least partially, 
the effects of  high fructose intake in the induction of  metabolic 
syndrome and provide new insights into the effect of  fructose on 
metabolic syndrome.
Materials and Methods
Animal treatment
The experimental protocol was approved by the ethics commit-
tee of  the Universidade Federal de São Paulo (process number 
0590/10).
Male Wistar rats weighing 200–250 g were divided into three 
groups. One group was treated with tail injection of  streptozo-
tocin at low concentration (STZ, Sigma, St. Louis, Mo, USA; 30 
mg/kg dissolved in sodium citrate buffer, pH 4.5) and fed with 
20% HFID+STZ in drinking water for 90 days. The second group 
was fed only with a 20% HFID in drinking water for 90 days, and 
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the third group received tap water during the entire period and 
was used as the control (CTL).
In some experiments, as indicated in the text, the animals were 
fed during the experimental protocol with a 2% fructose diet. All 
animals had free access to standard rat chow and tap water during 
experimental protocol.
At 0 (baseline), 30, 60, and 90 days after the beginning of  the 
experimental protocols, blood samples were collected from the 
retinal or the tail vein, and the animals were maintained in meta-
bolic cages for 24 h for urine collection.
The animals were killed after 90 days and both the right and left 
kidneys were removed for histological analyses. Biochemical pa-
rameters were determined by analyzing plasma and urine samples.
Biochemical analysis
Plasma glucose concentration was determined for all rats by ana-
lyzing tail blood samples (Accuchek, Boehringer Mannheim, In-
dianapolis, Ind., USA). The levels of  blood creatinine, urea, and 
urinary protein were assayed spectrophotometrically according to 
standard procedures using commercially available diagnostic kits 
(Labtest Diagnostica, Minas Gerais, Brazil). Creatinine was deter-
mined by using the Jafé reaction [12], and urea was determined by 
measuring urease activity [13]. Serum uric acid was determined by 
the uricase enzyme reaction based on the formation of  allantoin 
and hydrogen peroxide [14].
Plasma triglycerides were assessed by measuring hydrolyzation by 
lipase, which results in the formation of  glycerol and fatty ac-
ids; glycerol reacts with glycerol kinase followed by oxidase in a 
system that forms hydrogen peroxide [15]. HDL cholesterol was 
assessed by precipitation of  lipoproteins followed by quantifica-
tion of  HDL in the supernatant. The samples were hydrolyzed 
with cholesterol esterase and cholesterol oxidase, forming hydro-
gen peroxide [16]. The hydrogen peroxide formed in the reactions 
described above was analyzed by performing the horseradish per-
oxidase reaction in a chromogenic system.
Urinary protein was analyzed by using the pyrogallol red-molyb-
date method [17]. The results were expressed in mg/dL for cre-
atinine, urea, uric acid, triglycerides, HDL cholesterol, and mg/24 
h for urinary protein. Urine volume was expressed in mL, rat 
weight was expressed in grams, and urinary sodium was analyzed 
with flame photometry (Micronal B462, São Paulo, Brazil) and 
expressed in mEq/24 h.
Lipid peroxidation
Lipid peroxidation was determined in urine samples by quanti-
fying TBARS (thiobarbituric acid reactive substances). The reac-
tive substances combine with thiobarbituric acid, forming a red 
compound whose concentration can be assessed spectrophoto-
metrically at an absorbance of  535nm. The thiobarbituric acid 
assay was performed as described previously [18]. Malondialde-
hyde (MDA) was used to generate a standard curve, and the re-
sults were expressed as nM of  MDA/mg creatinine. Urine sam-
ples were added to a solution of  0.375% thiobarbituric acid, 15% 
trichloroacetic acid, and 0.25 N HCl (Sigma-Aldrich, St. Louis, 
USA), after which they were continually agitated while heated to 
95°C for 20 min. Subsequently, the samples were allowed to cool 
to room temperature. Assessment of  the creatinine level in urine 
samples was performed as previously described and used to nor-
malize the results of  MDA.
Urinary Hydroperoxide
Urinary levels of  hydroperoxides were measured using the ferrous 
oxidation method with Xylenol Orange called FOX2 assay for 
lipid hydroperoxide [19]. Briefly, 100-μL aliquots of  urine were 
transferred into microcentrifuge vials followed by the addition of  
900 μL FOX2 reagent.
After incubation at room temperature for 30 min, the vials were 
centrifuged at 12,000 rpm at 25°C for 10 min. The absorbance of  
the supernatant was then determined at 560 nm. Lipid hydroper-
oxide content in urine samples was determined according to the 
molar coefficient (4.3 104 M-1cm-1). Assessment of  the creati-
nine level in urine samples was performed as previously described 
and used to normalize the results of  urinary hydroperoxide meas-
urements.
Histological analysis
The kidneys were dissected along the nonhilar axis and fixed in 
10% phosphate-buffered formalin (Erviegas, São Paulo, Brazil). 
Kidney sections were fixed with 4% buffered paraformaldehyde 
and embedded in paraffin (Erviegas, São Paulo, Brazil). Four-mi-
crometer thick sections were cut for Masson’s Trichrome (TM; 
Erviegas, São Paulo, Brazil) and Periodic Acid Schiff  (PAS; Ervie-
gas, São Paulo, Brazil) staining, and then examined by performing 
light microscopy in a blinded manner.
The morphometric study was performed in kidney sections 
stained with PAS and TM in a Leica image analyzer computer sys-
tem (Hessen, Germany). The glomerular analyzes is represented 
by the renal corpuscle area, glomerular tuft area, and the Bowman 
space, as shown by the difference between them in PAS-stained 
sections. The fraction of  PAS-positive staining areas within the
glomerular tuft area was measured in 10 randomly selected glo-
meruli to indicate the mesangial matrix expansion.
The kidney sections stained with TM were used to evaluate fibro-
sis in the glomeruli. The percentage of  the area stained blue was 
measured per unit tuft area in 15 randomly selected glomeruli per 
animal.
Statistical Analysis
The results are expressed as a mean ± SE. The data were analyzed 
by one-way ANOVA followed by Tukey’s test. A value of  p < 0.05 
was considered statistically significant.
Results and Discussion
Studies have suggested that a fructose diet combined with other 
stimuli such as a high-fat diet [10, 20] or even a fiber-free white 
flour diet [11] could mimic metabolic syndrome in animal mod-
els. The hypothesis of  the present study was that low doses of  
streptozotocin could accelerate or potentiate the symptoms of  
metabolic syndrome.
Tables 1 and 2 show the biochemical parameters measured in the 
CTL, HFID, and HFID+STZ groups. The STZ+HFID animals 
gained significantly more weight than control or HFID animals 
after 30 days of  treatment (Table 1).
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No persistent increase in plasma glucose levels was detected in 
any of  the experimental groups in comparison to the control 
group, and a significant increase was observed in the STZ+HFID 
animals only at the beginning of  the experiment (Table 1).
The fructose diet induced a significant increase in uric acid after 
30 days in the HFID group and after 90 days in the STZ+HFID 
group, and a persistent increase in plasma triglycerides was ob-
served in both groups in comparison to the control group after 
30 days of  diet. The percentage increase was 210% and 251% 
in plasma triglycerides after 90 days of  diet in the HFID and 
STZ+HFID groups, respectively (Table 2). Nevertheless, a small 
increase in HDL cholesterol was detected after 30 days of  diet in 
the HFID and STZ+HFID groups.
The same observations were reported in other studies. Animals 
fed with fructose developed hypertension, hyperuricemia, and hy-
pertriglyceridemia, and these effects increased progressively with 
an increase in fructose intake from 10 to 60% of  fructose [9].
The correlation between these signs may be an increase in uric 
acid or alterations of  the oxidant/antioxidant status. A high-fruc-
tose diet induced hypertension, liver steatosis, hyperinsulinemia, 
and hypertriglyceridemia, and these effects were prevented by al-
lopurinol treatment. Uric acid also increased the oxidant status of  
the animals treated with fructose [21, 22].
The streptozotocin treatment together with the high-fructose diet 
(20%) potentiated some of  the signs of  metabolic syndrome in 
our experimental model, such as body weight, plasma glucose, 
and triglyceride levels. These results suggest that low doses of  
streptozotocin can accelerate the development of  metabolic syn-
drome.
The kidney function analyzes showed that in both groups ana-
lyzed, HFID and STZ+HFID, the diuresis increased after 60 days 
Table 1: Physiological Parameters
Days Weight(g) Blood Glucosis (mg/dL) Urine Volume (mL)
Creatinine serum 
(mg/dL) Urea (mg/dL)
Control 0 375±11 83.2±4.8 13.8±1.9 0.50±0.13 34.4±2.3
30 395±10 79.8±2.8 11.8±2.0 0.61±0.07 28.5±4.7
60 437±8 87.0±2.3 9.9±1.8 0.52±0.14 29.2±1.3
90 458±9 95.8±5.3 12.0±2.0 0.63±0.07 28.0±1.3
HFID 0 396±6 82.8±5.1 10.7±0.9 0.36±0.05 35.5±7.2*
30 420±3 90.2±5.3 11.1±3.3 0.35±0.02 46.8±1.8
60 441±3* 103.0±6.6 31.0±3.4* 0.42±0.04 33.6±1.5*
90 442±2 106.6±5.3 36.2±2.8* 0.65±0.09 36.8±0.8
STZ+HFID 0 411±6 93.2±3.0* 9.1±1.3 0.40±0.08 48.5±5.8
30 444±7* 108.0±6.2* 14.6±3.6 0.03±0.06 40.8±0.7
60 468±8* 108.0±4.8 42.8±1.7* 0.40±0.06 28.9±2.4
90 469±9* 106.7±4.8 34.6±2.3* 0.48±0.04 30.1±2.4
Table 2
Days
Urinary Protein 
(mg/24h) Uric Acid Serum (mg/dL)
Tryglicerydes 
(mg/dL) C-HDL (mg/dL)
Sodium Urinary 
(mEq/24h)
Control 0 6.6 ± 0.5 1.60 ± 0.75 64.6 ± 4.7 52.3 ± 5.3  0.57 ± 0.02
30 4.8 ± 0.4 1.21 ± 0.27 45.5 ± 1.3 46.3 ± 1.5  ND
60 4.1 ± 0.5 0.88 ± 0.01 60.3 ± 2.4 49.2 ± 3.4  ND
90 4.8 ± 0.6 0.83 ± 0.38 55.0 ± 4.5 52.5 ± 4.3  0.63 ± 0.09
HFID 0 5.5 ± 0.9 1.58 ± 0.49 59.6 ± 18.8 55.1 ± 8.1 0.48 ± 0.08
30 3.5 ± 1.0 3.75 ± 0.23*  75.9 ± 26.7 58.4 ± 2.2* ND
60 16.6 ± 2.4* 1.45 ± 0.07*  137.9 ± 2.0*  57.9 ± 4.7 ND
90 10.7 ± 0.5* 1.38 ± 0.31 115.7 ± 5.7* 56.1 ± 0.6 0.39 ± 0.07
STZ+HFID 0 6.5 ± 0.5  1.33 ± 0.07 59.6 ± 18.8 62.6 ± 4.5 0.48 ± 0.07
30 3.7 ± 1.0 1.65 ± 0.32 70.9 ± 6.4*  68.9 ± 4.7* ND
60 25.1 ± 4.8* 1.25 ± 0.13  192.0 ± 18.8* 59.5 ± 6.3  ND
90 12.8 ± 2.8* 2.38 ± 0.19*  149.7 ± 38.1*  64.8 ± 2.7 0.35 ± 0.03*
(*)p< 0.05 vs. CTL 
Data were expressed as the mean ± SEM. The parameters were analyzed in the CTL (control), HFID (high fructose intake diet, 20%), 
STZ+HFID (streptozotocin, 30 mg/mL and high fructose intake diet, 20%) groups at 0, 30, 60, and 90 days of  diet.
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of  diet (Table 1). In HFID and STZ+HFID, the increase was 
301% and 288%, respectively. Although, no differences in creati-
nine or urea were observed in the HFID and STZ+HFID groups 
in comparison to the control group (Table 1).
Table 2 shows the increase in urinary protein in the HFID and 
STZ+HFID groups after 30 days of  diet and a decrease in urinary 
sodium only in the STZ+HFID group (45%) after 90 days of  diet 
in comparison to the control group. Interesting in STZ+HFID 
group the diuresis and the urinary protein were higher than fruc-
tose fed animals, suggesting that the effects of  fructose in the 
kidney function were potentiated by streptozotocin treatment.
Figure 1 shows the urinary lipid peroxidation (A) and urinary hy-
droperoxides (B) in the HFID and STZ+HFID groups in com-
parison to the values in the control group. No difference in uri-
nary hydroperoxides was detected between the groups at baseline 
(0 time); however, there was a significant increase in urinary hy-
droperoxides in the HFID group (107.9 ± 31.9 versus 23.8 ±10.0 
nM/mg of  creatinine compared with the control) after 90 days (p 
< 0.05). This increase was related to the high-fructose diet, as in-
dicated by the fact that when animals were fed a 2% fructose diet 
for 90 days (13.6 ± 1.6 nM/mg of  creatinine), there was no in-
crease in lipid peroxidation. No significant increase was observed 
in the STZ+HFID, although a tendency towards an increase was 
observed in lipid peroxidation (63.0 ± 21.7 nM/mg of  creatinine) 
(Figure 1A).
This result was confirmed by quantification of  urinary peroxides 
(Figure 1B). We observed a significant increase in urinary hydrop-
eroxides in the HFID group (752 ± 190 versus 87.7 ± 29.8 nM/
mg of  creatinine compared with control group) after 90 days of  
Figure 1. (A) Urinary hydroperoxides (nM/mg creatinine)(B) TBARS levels (nM/mg creatinine) in the control group (CTL) , HFID 
(high fructose intake diet) and rats treated with streptozotocin and high fructose induced diet (STZ+HFID) at 0 and 90 days.
Figure 2. (A) Light microscopy of  kidney sections stained with Periodic Acid Schiff  (PAS) at 400× and Masson Trichrome stain (TM) 
at 200× in control rats (CTL), HFID (high fructose intake diet) and rats treated with streptozotocin and high fructose induced diet 
(STZ+HFID). (B) Quantification of  glomerular tuft, glomerular area, and Bowman’s space expressed in μm2, PAS glomerular stain in 
counts/μm2 and TM glomerular stain in counts/μm2.
B
A
International Journal of Food Science, Nutrition and Dietetics, 2014 © 113
Fernanda Teixeira Borges, et al (2014) Kidney Function in Rats Treated With a High-Fructose Diet and Streptozotocin. Int J Food Sci Nutr Diet. 3(4), 109-114.
diet, but not in animals fed a 2% fructose diet (175.2 ± 39.1 nM/
mg of  creatinine) or in the STZ+HFID group (130.7 ± 73.7
nM/mg of  creatinine).
Taken together these results suggest that a high-fructose diet sig-
nificantly increased lipid peroxidation as a consequence of  oxida-
tive stress and the inhibition of  antioxidant defenses, as reported 
previously [23, 24]. Nevertheless, low doses of  streptozotocin 
together with a high fructose diet attenuates the increase in lipid 
peroxidation, although the consequences of  this effect remain to 
be determined. One hypothesis is that fructose consumption re-
sults in ATP depletion, and the AMP generated enters into the 
purine degradation pathway and increases uric acid levels, which 
together with the fructose can result in oxidative stress [25]. In 
our experimental model, the increase in uric acid plasma concen-
tration was delayed in animals treated with streptozotocin and fed 
with fructose in comparison to the group that only received the 
carbohydrate.
Figure 2 shows the results of  morphometric analyses of  kidney 
sections from HFID and STZ+HFID animals compared to those 
of  the control group after 90 days of  high-fructose diet. The re-
nal corpuscle area was increased in both groups fed with fruc-
tose (HFID: 9062 ± 373 μm2; STZ+HFID: 9248 ± 368 μm2) in 
comparison to that in the control group (CTL: 8076 ± 328 μm2) 
(Figure 2A).
Interestingly, in the HFID group, the glomerular tuft area (6802 ± 
298 μm2) was increased in comparison to that in the STZ+HFID 
group (5321 ± 209 μm2) and the control group (5446 ± 230 μm2). 
Nevertheless, Bowman’s space was increased in the HFID+STZ 
(3927 ± 244 μm2) in comparison to the control (2630 ± 163 μm2) 
and HFID (2260 ± 158 μm2) groups (Figure 2 A and B). This 
result suggests that in both experimental situations, the renal 
corpuscle was increased, although this increase was related to an 
increase in Bowman’s space in the STZ+HFID group and to an 
increase in glomerular filtration area in the HFID group.
It is also important to point out that in the STZ+HFID group, 
there was a significant increase in PAS stain (11,912 ± 611 count/
μm2) in comparison to the control (9,889 ± 636 count/μm2) and 
HFID (10,893 ± 669) groups, suggesting that the protein glucose 
residue increased in the glomerular filtration area (Figure 2 A and 
B). No increase in TM positive staining was observed in the ex-
perimental groups when compared to the control group; however, 
a significant decrease was observed in both experimental groups.
Taken together these results showed that animals treated with 
streptozotocin and fed a high fructose diet showed an increase 
in renal corpuscle area, basement membrane thickness, urine 
volume, and protein excretion, and a decrease in urinary sodium 
excretion, suggesting impairment in kidney function in animals 
treated with streptozotocin and fed with fructose. Although in 
animals fed with high fructose, the kidney analyses showed an 
increase in glomerular tuft area, a concomitant increase in protein 
excretion and urine volume also suggested an increase in glomer-
ular filtration rate.
Fructose and glucose can glycate the glomerular basement mem-
brane and increase its permeability [26]. Additionally, fructose 
itself  can increase tubular sodium reabsorption [27], and this 
effect appeared to be potentiated in streptozotocin-treated and 
fructose-fed animals in comparison to the other groups analyzed.
Taken together, the results of  the present study suggest that the 
association of  a high fructose diet with low or mild pancreatic 
lesions promoted by low doses of  streptozotocin accelerate, at 
least partially, the signs of  metabolic syndrome. Additionally, our 
results provide new insights about the effects of  prolonged high 
fructose intake combined or not with low doses of  streptozotocin 
on the kidney.
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